I Asturias International Meeting on Clinical Microbiology and Infectious Diseases
Clinical microbiology and infectious diseases are specialties in constant expansion and, while great inroads are being made, the challenges remain complex in these fields. Multidrug resistant bacteria (including tuberculosis) are spreading worldwide, making it difficult to treat the infections they cause and posing a very real threat to healthcare systems and public health. New antimicrobials are in the pipeline, but experience with them is as yet insufficient. Likewise, new technology-based diagnostic tools are continuously being developed. Diagnostic and antimicrobial stewardship programs are essential both in hospitals and in the community to optimize diagnosis and treatment with new antimicrobials, as well as with older drugs. Among these refractory infections, sexually transmitted diseases are once again on the rise, due to emerging pathogens and resistances. Other new diseases are also of concern, such as those caused by tropical viruses (Ebola, Chikungunya…) and fungi, (Candida auris) as well as other viruses and molds affecting immunocompromised patients whose numbers are escalating across the globe. Research in microbiology is currently in the spotlight of science. One example of such are studies into microbiome that are able to answer previously open questions. Furthermore, technologies such as next generation sequencing or genome editing using CRISPR-Cas9 are promising in clinical microbiology, albeit their applicability are far from easy.